Naploy Corp., a Wyoming-incorporated health news and mobile app startup, filed its annual report on Form 10-K with the SEC on October 30, 2026, covering the fiscal year ended July 31, 2026.

Key Highlights

  • No revenue: The company disclosed it "has no sufficient revenue and has incurred losses since inception."
  • Share count: 3,803,370 common shares were issued and outstanding as of October 30, 2026.
  • Aggregate market value: The filing reported $0 as the aggregate market value of voting and non-voting common equity held by non-affiliates as of the last business day of the most recently completed second fiscal quarter.
  • No employees: The company reported no employees other than its two officers and directors, Mr. Frederick Sidney Reinhard Arnold and Mr. Rafael Angel Ulloa Bonilla.
  • Incorporated April 6, 2023: Naploy Corp. was established on that date in the State of Wyoming, with its principal offices located in Abuja, Nigeria.
  • Emerging growth company: The registrant is classified as a non-accelerated filer, smaller reporting company, and emerging growth company, and has elected not to use the extended transition period for new or revised accounting standards.

Naploy Corp. Business Overview: Health News App and Symptom Diagnostic Tool

According to the filing, Naploy Corp.'s primary focus is "on launching a news blog that provides the latest updates on health-related topics, including but not limited to medical breakthroughs, healthy lifestyle tips, and updates on healthcare policies." The company's main product, the Naploy App, is available on both Android and iOS operating systems and includes an article library covering nutrition and diet, fitness, weight control, diseases, disease management, and health research, the filing stated.

The filing described a Symptom Diagnostic feature as "an advanced tool that uses high-grade AI technology to provide diagnoses," noting that users enter age, gender, symptoms, intensity, and duration, and the tool then returns a list of approximately five possible conditions. The company disclosed that this feature "does not provide medical advice" and "is intended for informational purposes only," and that users are strongly encouraged to consult an actual physician. The filing further stated that the Naploy App and Symptom Diagnostic feature "do not require regulatory approval in the United States, Nigeria or elsewhere because they provide information rather than direct medical advice."

A third feature, Clinic Search, allows clients to submit requests for clinic and medical service information for a fee, according to the filing. The company's securities are registered under Section 12(g) of the Exchange Act as ordinary shares with a par value of $0.0001 per share. No trading symbol or exchange listing was reported under Section 12(b).

What Was Disclosed

Naploy Corp. filed a 10-K annual report for the fiscal year ended July 31, 2026, disclosing no sufficient revenue, losses since inception, zero non-affiliate market value, 3,803,370 shares outstanding, and a two-person officer and director team operating a health news and app business from Abuja, Nigeria.